As of April 2024 Paratek Pharmaceuticals has a market cap of $0.12 Billion. This makes Paratek Pharmaceuticals the world's 7231th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.12 B | 0% |
2023 | $0.12 B | 23.06% |
2022 | $0.10 B | -53.9% |
2021 | $0.22 B | -21.13% |
2020 | $0.28 B | 78.01% |
2019 | $0.16 B | -3.01% |
2018 | $0.16 B | -66.91% |
2017 | $0.50 B | 43.53% |
2016 | $0.34 B | 4.32% |
2015 | $0.33 B | -39.9% |
2014 | $0.55 B | 777.91% |
2013 | $63.31 M | -23.82% |
2012 | $83.1 M | -21.6% |
2011 | $0.10 B | 6.51% |
2010 | $99.52 M | 9.36% |
2009 | $91.01 M | 134.13% |
2008 | $38.87 M | -48.63% |
2007 | $75.67 M | -41.87% |
2006 | $0.13 B |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Ultragenyx RARE | $3.48 B | 2,629.09% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | $0.21 B | 65.38% | ๐บ๐ธ USA |
Agenus
AGEN | $0.11 B | -12.99% | ๐บ๐ธ USA |